Background
Fluoroquinolone (FQ) antimicrobials are important in the treatment of a range of infections, including urinary tract infections (UTIs). They have a broad spectrum of activity, high bioavailability, convenient dosing regimens, and high potency [
1,
2]. FQs are listed as an essential medicine by World Health Organization (WHO) [
3]. Their extensive use has led to a marked increase in FQ resistance globally [
4‐
7].
Quinolone/fluoroquinolone (Q/FQ) resistance in
Enterobacterales is commonly attributed to chromosomal mutations in the quinolone resistance-determining region (QRDR) of the genes encoding subunits of DNA gyrase (GyrA and GyrB) and topoisomerase IV (ParC and ParE) [
8]. The reduction of Q/FQ concentration in the cytoplasm by chromosomal efflux pumps or permeability alterations also contributes to resistance [
9]. Transferrable mechanisms of quinolone resistance (TMQR) can additionally confer low-level Q/FQ resistance and promote the development of full resistance [
10]. TMQR determinants include seven Qnr proteins, AAC(6’)-Ib-cr (an aminoglycoside acetyltransferase), and two efflux pumps, QepA and OqxAB. Qnr proteins (QnrA, QnrB, QnrC, QnrD, QnrE, QnrS, and QnrVC) are dimeric proteins belonging to the pentapeptide repeat protein (PRP) family and protect DNA gyrase and topoisomerase IV from the action of quinolones [
11]. The AAC(6’)-Ib-cr is a bifunctional variant of AAC(6’)-Ib that imparts resistance to aminoglycosides and fluoroquinolones having a piperazinyl substituent, such as ciprofloxacin and norfloxacin, via acetylation of amino nitrogen in the piperazinyl ring [
11]. These diverse mechanisms can act in concert to confer non-susceptibility to Q/FQ.
As the use of FQ is restricted in children [
12], the increase in FQ resistance among the pediatric population is important [
13,
14]. In a recent study from our institution, 66 (41.8%) of 158
E. coli and 7 (23.3%) of 30
K. pneumoniae isolates causing UTI among children were resistant to ofloxacin [
15]. Studies from tertiary care centers of Nepal focusing on pediatric UTI have reported ciprofloxacin resistance in 576 (78%) of 739 and 44 (63%) of 69 isolates, and ofloxacin resistance in 104 (62%) of 168
E. coli isolates [
16‐
18]. We have investigated the occurrence of TMQR among quinolone-resistant
E. coli and
K. pneumoniae isolates causing UTI among children at our institution and sought to identify molecular characteristics of TMQR-harboring isolates.
Materials and methods
Study design and setting
This is a retrospective study conducted at Siddhi Memorial Hospital (SMH), Bhaktapur, Nepal. SMH is a 50-bedded secondary care maternal and pediatric hospital with 10 pediatric ICU beds, serving about 16,000 pediatric OPD visits annually. E. coli and K. pneumoniae isolates obtained from UTI patients less than 18 years old attending the outpatient department (OPD) of the hospital were included in the study. An anonymized dataset, with personal identifiers removed, containing the patient’s age, sex, name of the pathogen, and the susceptibility result to nalidixic acid from June 2018 to February 2021 was retrieved from the microbiology laboratory.
Microbiological methods at the time of isolation of the isolates
Clean catch mid-stream urines were collected from children suspected of UTI as per the pediatrician’s discretion as a part of routine patient diagnosis. Urine cultures were performed by semi-quantitative method on a cysteine-lactose-electrolyte deficient agar (CLED) plates which were then incubated at 37 oC for 18–24 h aerobically. Urine cultures with a growth of ≥ 105 CFU/mL were considered for further processing.
The presumptive identification of the pathogens was performed by Gram stain, colony morphology, and a panel of in-house biochemical tests. Susceptibility to nalidixic acid (NA) was performed by the Kirby Bauer disk diffusion method [
19]. Significant isolates were stored at -40
oC at the time of isolation.
E. coli and K. pneumoniae isolate resistant to NA were sub-cultured from the frozen stocks on a MacConkey agar and sheep blood agar till uniform well-isolated colonies were obtained. The investigations carried out in this study include antimicrobial susceptibility testing and molecular investigations for the detection of β-lactamases, TMQR genes, and mutations in gyrA and parC.
Antimicrobial susceptibility testing
Antimicrobial susceptibility testing (AST) of
E. coli and
K. pneumoniae isolates was performed by the Kirby Bauer disk diffusion method according to the CLSI guideline [
19]. The antimicrobial disks used for testing were ampicillin (10 µg) [tested only for
E. coli], amoxicillin-clavulanic acid (20/10 µg), piperacillin-tazobactam (100/10 µg), cefazolin (30 µg), cefuroxime (30 µg). cefixime (5 µg), cefotaxime (30 µg), ceftazidime (30 µg), cefepime (30 µg), imipenem (10 µg), ciprofloxacin (5 µg), trimethoprim sulphamethoxazole (1.25/23.75 µg), nitrofurantoin (300 µg), and amikacin (30 µg). Amoxicillin-clavulanic acid, piperacillin-tazobactam, ceftazidime, ciprofloxacin, and imipenem disks were purchased from the manufacturer Mast (Mast group Ltd, Liverpool, UK) with the remainder from HiMedia (HiMedia, India). The minimum inhibitory concentration (MIC) of ciprofloxacin was determined by E-test (0.002-32 µg/mL) (HiMedia, India), and those isolates with MIC ≥ 32 µg/mL were further tested by agar dilution method following the procedures described by CLSI [
20]. An isolate was defined to display multidrug resistance (MDR) if non-susceptible to ≥ 1 agent in ≥ 3 antimicrobial categories [
21].
Escherichia coli ATCC 25922 was used for quality control.
The genomic DNA was extracted using Qiagen DNA mini kit (Qiagen, Hilden, Germany) following the procedures described by the manufacturer with the only exception that the final elution was made with 150 µl of nuclease-free water (NFW). The DNA extracts were quantified using Qubit 4 Fluorometer (Invitrogen, Thermo Fisher Scientific) following the manufacturer’s recommendations.
Characterization of β-lactamases
The phenotypic determination of extended-spectrum β-lactamase (ESBL) production was first performed by a combination disc diffusion method with cefotaxime, cefotaxime-clavulanic acid, ceftazidime, and ceftazidime-clavulanic acid (D62C and D64C, Mast group Ltd, Liverpool, UK). The results were interpreted as described in the CLSI guideline [
19]. DNA samples of the ESBL-positive isolates were analyzed by PCR to detect
blaCTX−M [
22],
blaSHV (for
E. coli only), and
blaTEM by the assays described elsewhere [
23].
The modified carbapenem inactivation method (mCIM) was used to confirm carbapenemase production among imipenem non-susceptible isolates as described in the CLSI guideline [
19]. DNA samples of these isolates were analyzed by PCR to detect
blaNDM,
blaOXA−48,
blaKPC,
blaIMP, and
blaVIM using the primers published previously [
24].
Escherichia coli ATCC 25922 and clinical strains confirmed to harbor blaCTX−M, blaTEM, and blaSHV β-lactamase genes were used for quality control for ESBL phenotyping and genotyping. Previously characterized strains confirmed to harbor blaNDM and blaOXA−48 were used as positive controls for mCIM. DNA extracted from the control strains was used as a positive control, and Escherichia coli ATCC 25922 DNA was used as a negative control in PCR assays.
Detection of TMQR genes
Previously validated multiplex PCR assay for the detection of TMQR genes was used for the detection of
qnrA, qnrB, qnrS, oqxAB (reported only for
E. coli),
qepA, and
aac(6’)-Ib-cr [
25]. Briefly, the PCR reaction mixture of 50 µl was prepared with 25 µl of multiplex PCR master mix (2X) (Qiagen, Hilden, Germany), 5 µl of the pool of primers containing 2 µM of each primer, 5 µl of template of concentration of 20 ng/µl, and 15 µl of NFW (Ambion™ Nuclease-Free water, Invitrogen, Thermo Fisher Scientific). The PCR amplification was carried out in Veriti 96 Well Thermal Cycler (appliedbiosystems, Thermo Fisher Scientific) with 15 min of initial denaturation at 95
oC followed by 30 cycles of denaturation at 94
oC for 30 s, annealing at 63
oC for 90 s, and extension for 10 min at 72
oC. The amplification products were first resolved by gel electrophoresis (1.5%, w/v) at 100 V for 40 min and visualized in a gel documentation system (Major Science, California, USA). All PCR amplicons of
qnr genes were sequenced and confirmed by BLAST (Basic Local Alignment Search Tool).
Detection of mutations in gyrA and parC
A convenience sample of thirty-five TMQR-positive isolates with representative ciprofloxacin’s interpretive categories (susceptible, intermediate, and resistant) for
E. coli and
K. pneumoniae were selected for the amplification of the gene fragment covering the QRDR of the
gyrA [
26] and
parC [
27]. None of the
K. pneumoniae isolates with a TMQR gene were susceptible to ciprofloxacin. The
gyrA and
parC amplicons were purified and subjected to bi-directional DNA sequencing by capillary electrophoresis (Macrogen, South Korea).
The chromatograms were visualized and processed in BioEdit software, and the sequences were then imported into MEGA11 software. In MEGA11 alignment explorer, the sequences were aligned by the ClustalW algorithm followed by codon-based nucleotide alignment. The substitutions in the QRDR of GyrA and ParC were determined by comparing the amino acid sequences of the isolates to the amino acid sequences of E. coli ATCC 25922 (GenBank Accession number NZ_CP032085 for gyrA, NZ_CP009072 for parC) and Klebsiella pneumoniae ATCC 13883 (GenBank Accession number DQ673325 for gyrA, KFJ75438 for parC).
Data analysis
The data were collected in a Microsoft Excel spreadsheet and imported to IBM SPSS Statistics for Windows v.20 (IBM Corp, Armonk, NY). A chi-squared test of independence or Fisher exact test was performed to determine whether there was a significant relationship between TMQR and other categorical variables. The difference in ciprofloxacin MIC among TMQR positive and negative isolates was investigated by the Mann-Whitney U test. A cutoff value of ≤ 0.05 for the P-value was considered for statistical significance.
Discussion
This study demonstrates alarmingly high levels of FQ resistance among E. coli and K. pneumoniae isolates causing UTI in children attending the outpatient department of Siddhi Memorial Hospital, Bhaktapur, Nepal. Half of the isolates were TMQR positive which suggests that TMQR genes may have an important role in the emergence of quinolone resistance in E. coli and K. pneumoniae isolates within our study population. TMQR genes were found to have a statistically significant association with two β-lactamases, blaCTX−M and blaTEM.
We found a high prevalence of TMQR in diverse gene combinations among study isolates. Similar high proportions of the TMQR genes have been reported in previous studies, while few studies have comparatively lower proportions. The proportion of TMQR positivity among FQ-resistant isolates we report, 68/132 (51.5%) of ciprofloxacin-resistant isolates, is similar to a study from the Netherlands (29/ 56, 51.8%) [
28], higher than in Korea (13/122, 10.7%) [
29], Taiwan (37/248, 14.9%) [
30], and China (137/302, 45.4%) [
31], and lower than in Iran (54/60, 90%) [
32], South Africa (47/48, 98%) [
33], and Egypt (90/90, 100%) [
34]. Studies from China, Korea, and Taiwan investigated solely the
E. coli isolates and the Iran study included
E. coli and
K. pneumoniae. The rest of the three studies had various
Enterobacterales isolates. The proportion and distribution of TMQR genes vary among different studies possibly due to the heterogeneity in the isolate selection criteria, the specific TMQR genes investigated, and the study population. Also, the actual proportion of TMQR could be slightly higher than reported in this study among uropathogens at our institution because they can be present even among nalidixic acid-susceptible
Enterobacterales [
11]. Since we only included nalidixic-resistant isolates, we might have missed isolates with such phenotype.
The distribution of the TMQR genes observed in this study is consistent with the general distribution reported by previous studies. We found the highest prevalence for three TMQR genes;
aac(6’)-Ib-cr (n = 48, 32.7%),
qnrB (n = 23, 15.7%), and
qnrS (n = 18, 12.3%) (Table
2). In line with this study, the
aac(6’)-Ib-cr gene was the most common TMQR gene among FQ-resistant
E. coli in the investigation in South Korea (11/122, 9%) [
29], China (74/302, 24.5%) [
31], and Netherlands (23/56, 41.1%) [
28]. Studies from Iran, South Africa, China, Taiwan, and Egypt found
qnrB and
qnrS as the most common compared to other
qnr genes investigated among FQ-resistant clinical isolates, in agreement with our findings [
30‐
34]. On the other hand, the prevalence of
oqxAB or
oqxA/B in Iran [
oqxA: 22/60 (36.7%),
oqxB: 31/60 (51.7%)], South Africa [
oqxA: 20/48 (41.7%),
oqxB: 43/48 (89.6%)], China [
oqxAB: 19/302 (6.3%)], and Taiwan [
oqxAB: 15/248 (6.1%)] is contrary to our findings; we only found one
E. coli isolate with
oqxAB gene among 125 isolates investigated [
30‐
33]. No isolate was found to harbor
qepA gene similar to the study in the Netherlands and Taiwan [
28,
30], but 3/60 (5.0%), 9/90 (10.0%), and 36/302 (11.9%) of FQ-resistant isolates were found to possess
qepA in Iran, Egypt, and China, respectively [
31,
32,
34]. Overall, our data in conjunction with the previous findings suggest that
aac(6’)-Ib-cr and the two
qnr genes,
qnrB and
qnrS, are the most prevalent TMQR genes among Q/FQ-resistant
Enterobacterales in general. A recent study demonstrated that possession of
aac(6’)-Ib-cr gives a selective advantage to
E. coli ST131 in the presence of ciprofloxacin [
35]. In addition, alone or in combination with chromosomal mutations, QnrS1 has been shown to increase bacterial fitness while QnrA1 and QepA2 decrease fitness [
11]. These observations could explain the predominance of
aac(6’)-Ib-cr and
qnrS, and the low prevalence of
qnrA and
qepA.
Our data show that TMQR-positive isolates have higher FQ MIC than those that lack them similar to studies from Iran and Korea [
36,
37]. The ciprofloxacin MIC values were significantly higher in TMQR positive isolates (Median = 64 µg/mL, n = 74) compared to TMQR negative isolates (Median = 32 µg/mL, n = 73) (Mann-Whitney U = 1969, Z=-2.871, p = 0.004, but with a small effect size of r = 0.24). Results from the analysis of 35 representative isolates suggest that the concomitant presence of GyrA and ParC substitutions accompanies TMQR genes to result in high levels of FQ resistance (Table
3). Similar findings of multiple substitutions in GyrA and ParC along with TMQR genes leading to high FQ resistance have been shown in other studies [
34,
38].
The statistically significant association of TMQR with ESBL observed in this study mirrors previous findings from several other studies [
36,
37,
39,
40]. The β-lactamase genotypes,
blaTEM and
blaCTX−M, showed an independent association with TMQR, but the difference in the proportion of
blaTEM was remarkably high between TMQR positive and TMQR negative group (47.3% vs. 1.4%) (Additional file 3: Table
1). Notably, of 57 ESBL-producing TMQR positive isolates, 29 (50.9%) co-harbored both
blaTEM and
blaCTX−M while no TMQR negative isolate had more than one β-lactamase gene (Table
2). These observations suggest that the association of β-lactamase and TMQR is driven by the co-existence of multiple β-lactamase genes rather than a single genotype in the study population. In a study from Iran investigating UTI caused by
Enterobacterales, 72 (43.6%) isolates had the co-existence of
blaCTX−M and
blaTEM among 165 ESBL-producing TMQR positive
E. coli and
K. pneumoniae isolates [
36]. In contrast, among 155 ESBL-positive TMQR harboring
K. pneumoniae (originating from various clinical specimens) in a study in Algeria, all 155 isolates had
blaCTX−M only [
41]. Geographic, demographic, and differences in clinical specimens could account for this disparity. The predominance of
blaCTX−M as the most common ESBL gene associated with TMQR is in an agreement with both Iranian and Algerian studies. We also demonstrate carbapenemase genes among TMQR-positive isolates, in contrast to previous findings; most studies either had no or negligible TMQR-positive isolate resistant to carbapenem [
31,
34,
39,
42]. Two-thirds (14/21, 66.7%) of the carbapenemase-producing isolates were TMQR-positive. Although, this was not a statistically significant association (Additional file 3: Table
1).
WHO’s GLASS report 2022 showed that more than 90% of antimicrobial use in Nepal in 2018 was attributed to oral administration reflecting their use in the community setting [
43]. Ciprofloxacin and cefixime were the second and third most consumed oral antimicrobials, respectively. Pathogens harboring resistance mechanisms for either or both of these two antimicrobials most likely thrived under such high selective pressure in the community. A recent study from a tertiary care center in Nepal with a large sample size (n = 2153) showed a high prevalence of isolates with overlapping resistance to extended-spectrum cephalosporin and fluoroquinolone in both inpatient and outpatient settings that is consistent with the hypothesis that these two groups of genes are co-spreading in Nepal [
44]. TMQR and ESBL genes can be located in the same conjugative plasmid with other antimicrobial-resistant determinants, and this facilitates their simultaneous spread and contributes to the emergence of MDR [
11]. Such co-localization implies that the use of either quinolones or β-lactams could also promote the selection of these strains as suggested in a study from Vietnam [
45]. Considering that fluoroquinolone is typically avoided in children, high levels of fluoroquinolone resistance may be explained by the high prevalence of such strains, promoted by selective pressure in the community, and by the spread of strains with co-localization of TMQR and β-lactamases within the same conjugative plasmids.
TMQR genes seem to have community origin [
42,
46], and several studies have shown that commensal gut microbiota frequently harbors these genes [
46,
47], as do isolates from other body surfaces [
48]. With the growing appreciation of the involvement of the gut microbiome [
49] and urinary microbiome in causing UTI [
50], the detection and characterization of TMQR genes from the microbiome of these niches could be a future investigation at our institution. Characterization of the genetic background of TMQR (such as TMQR copy number, and expression level), conjugation experiments, phylogrouping, and MLST could be another aspect of focus for further research. The lack of data on whether the patients had consumed antimicrobials prior to hospital visits is a limitation of this study. In addition, we have not characterized other mechanisms of quinolone resistance, such as chromosomal efflux pumps, permeability alterations, and the role of biofilms.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.